Search Results - neuroprotection

2 Results Sort By:
Bone Marrow Mesenchymal Stem Cell (BMSC)-Derived Exosomes for the Treatment of Glaucoma
Abstract: Glaucoma is one of the world’s leading causes of irreversible blindness. There is no cure and vision lost from glaucoma cannot be restored. Glaucoma is associated with fluid build-up in the eye resulting in an increased intraocular pressure (IOP). The pressure may cause damage to the optic nerve and lead to progressive degeneration of retinal...
Published: 12/6/2024   |   Inventor(s): Stanislav Tomarev, Benjamin Mead
Keywords(s): Degenerative Ocular Disease, Exosomes, GLAUCOMA, National Eye Institute, NEI, Neuroprotection, Retinal Ganglion Cell Loss, RGC, Tomarev, Vector Encoding miRNA, Vision Loss
Category(s): Collaboration Sought > Collaboration, Collaboration Sought > Licensing, Application > Therapeutics, TherapeuticArea > Ear, Nose, & Throat, TherapeuticArea > Ophthalmology
Isomer-specific Neuroprotective Effect of Natural Resveratrol
Reference #: 01516 The University of South Carolina is offering licensing opportunities for Isomer-specific Neuroprotective Effect of Natural Resveratrol Background: Resveratrol (RSV) has been used in clinical trials against a multitude of human disease conditions, including COVID-19 and Alzheimer’s Disease (AD). Although some of these studies...
Published: 1/6/2025   |   Inventor(s): Sajish Mathew
Keywords(s): cis-resveratrol, neuroprotection
Category(s): Health Sciences, Biomedical and Life Sciences